Sun Pharma Chairman Dilip Shanghvi described the Organon acquisition as both exciting and worrying due to its size and debt burden, while expressing confidence in repayment and highlighting expansion into China and biosimilars as key strategic gains
Hyderabad: Covid has tested and proved the credibility of the Indian pharma industry as one of the core sectors for the nation. The industry rose to the occasion by ramping up research and manufacturing to find solutions for the treatment. Pharma companies are optimistic that normalcy will return in the next one year. Speaking at […]
Hyderabad: Indian pharma industry is going through a lot of transformation and achieving scale. While export opportunities keep increasing, there is equal attention on strengthening the drug pipeline driven by research investments. Speaking at the CEO Conclave at BioAsia on Friday, Ajay Piramal, chairman, Piramal Group said, the company is increasing its investments onto more […]
“I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products,” the company MD said
